Exagen Inc. (XGN) has a consensus analyst rating of Buy, based on 10 analysts covering the stock. Of those, 10 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for XGN is $13.00, representing a +327.6% upside from the current price of $3.04. Price targets range from a low of $9.00 to a high of $15.00.
